Detalhe da pesquisa
1.
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 130(11): 1964-1971, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340331
2.
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Haematologica
; 108(9): 2331-2342, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951163
3.
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
Am J Hematol
; 98(11): 1711-1720, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635400
4.
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
Clin Infect Dis
; 75(9): 1503-1510, 2022 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325094
5.
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
Am J Hematol
; 97(7): 885-894, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413152
6.
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Clin Infect Dis
; 72(10): 1755-1763, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236406
7.
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax.
Cancer
; 127(20): 3772-3781, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255353
8.
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis.
Cancer
; 127(22): 4213-4220, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343352
9.
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.
Cancer
; 127(14): 2489-2499, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793970
10.
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality.
Am J Hematol
; 96(3): 282-291, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264443
11.
Treating Leukemia in the Time of COVID-19.
Acta Haematol
; 144(2): 132-145, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32392559
12.
The face of remission induction.
Br J Haematol
; 188(1): 101-115, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828798
13.
Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials.
Expert Opin Emerg Drugs
; 25(4): 491-499, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161749
14.
Optimizing patient selection for treatment-free remission.
J Oncol Pharm Pract
; 26(5): 1220-1224, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437235
15.
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
Mycoses
; 62(1): 81-86, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230043
16.
Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities.
J Oncol Pharm Pract
; 25(3): 747-753, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29554829
17.
Treatment of relapsed/refractory acute lymphoblastic leukemia.
Clin Adv Hematol Oncol
; 17(3): 166-175, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969955
18.
Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.
Clin Infect Dis
; 67(10): 1610-1613, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29771293
19.
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies.
Am J Hematol
; 93(3): 401-407, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218851
20.
Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin.
Future Oncol
; 13(25): 2233-2242, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28776425